GGrantIndex
← Search

CHARACTERIZATION OF IN VITRO CYTOXICITY & IN VIVO ANTITUMOR EFFICACY OF IMMUNOTOXIN HERV-K SCFV-RGEL FOR BREAST CANCER

$109,116FY2008Department of DefenseDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

View source on USAspending →
CHARACTERIZATION OF IN VITRO CYTOXICITY & IN VIVO ANTITUMOR EFFICACY OF IMMUNOTOXIN HERV-K SCFV-RGEL FOR BREAST CANCER · GrantIndex